AUDA
|
|
|
- CAS號(hào):
- 479413-70-2
- 英文名:
- AUDA
- 英文別名:
- AUDA;AUDA,≥98%;AUDA, 10 mM in DMSO;12-(3-adamantan-1-Y-L-Ureido)dodecaneacid;12-(3-adamantan-1-yl-ureido)dodecanoic acid;12-[[(tricyclo[3.3.1.13,7]dec-1-ylamino)carbonyl]amino]-dodecanoic acid;Dodecanoic acid, 12-[[(tricyclo[3.3.1.13,7]dec-1-ylamino)carbonyl]amino]-;Inhibitor,anti-inflammatory,epoxide,inhibit,hydrolase,sEH,activity,AUDA,soluble,Epoxide Hydrolase,VSMC
- 中文名:
- AUDA
- 中文別名:
- 化合物AUDA;12-(3-(金剛烷-1-基)脲基)十二酸;化合物AUDA,10 MM DMSO 溶液;12-(3-adamantan-1-YL-Ureido)十二烷酸
- CBNumber:
- CB32590311
- 分子式:
- C23H40N2O3
- 分子量:
- 392.58
- MOL File:
- 479413-70-2.mol
|
|
|
AUDA化學(xué)性質(zhì)
-
熔點(diǎn):
-
114 °C(Solv: hexane (110-54-3))
-
|
-
沸點(diǎn):
-
592.7±19.0 °C(Predicted)
-
|
-
密度:
-
1.09±0.1 g/cm3(Predicted)
-
|
-
儲(chǔ)存條件:
-
Sealed in dry,Store in freezer, under -20°C
-
|
-
溶解度:
-
DMSO: ≥10mg/mL at warmed to 60°C
-
|
-
形態(tài):
-
powder
-
|
-
酸度系數(shù)(pKa):
-
4.78±0.10(Predicted)
-
|
-
顏色:
-
white to beige
-
|
-
InChI:
-
1S/C23H40N2O3/c26-21(27)10-8-6-4-2-1-3-5-7-9-11-24-22(28)25-23-15-18-12-19(16-23)14-20(13-18)17-23/h18-20H,1-17H2,(H,26,27)(H2,24,25,28)/t18-,19+,20-,23-
-
|
-
InChIKey:
-
XLGSEOAVLVTJDH-UKBVAGSOSA-N
-
|
-
SMILES:
-
OC(=O)CCCCCCCCCCCNC(=O)NC12C[C@@H]3C[C@@H](C[C@@H](C3)C1)C2
-
|
AUDA性質(zhì)、用途與生產(chǎn)工藝
AUDA (compound 43) 是一種有效的 soluble epoxide hydrolase (sEH) 的抑制劑，對(duì)小鼠sEH和人sEH的IC50值分別為18 nM和69 nM。AUDA具有抗炎活性，可降低MMP-9、IL-1β、TNF-α 和 TGF-β。AUDA還可下調(diào) Smad3 和 p38 信號(hào)通路。
| Target | Value |
MMP-9
()
|
|
IL-1β
()
|
|
TNF-α
()
|
|
TGF-β
()
|
|
Smad3
()
|
|
AUDA (0.3-10 μg/mL; 48 hours) dose-dependently suppresses the proliferation of rat VSMCs exposed to PDGF.
AUDA (0.3-10 μg/mL; 30 min) dose-dependently upregulats COX-2 expression.
AUDA (10, 50 and 100 μM) augments the migratory ability of HCAECs in a dose-dependent manner.
AUDA significantly increases the adhesion ability of HCAECs.
Cell Proliferation Assay
|
Cell Line:
|
Vascular smooth muscle cell (VSMC)
|
|
Concentration:
|
0.3, 1, 3, 10 μg/mL
|
|
Incubation Time:
|
48 hours
|
|
Result:
|
Dose-dependently suppressed the proliferation of rat VSMCs exposed to PDGF.
|
Western Blot Analysis
|
Cell Line:
|
VSMC
|
|
Concentration:
|
1, 3, 10, 30 μg/mL
|
|
Incubation Time:
|
30 min
|
|
Result:
|
Dose-dependently upregulated COX-2 expression.
|
AUDA (i.p.; 10 mg/kg; 14 days) reduces TNF-α, MMP-9 and IL-1β expression levels.
|
Animal Model:
|
Male (wild-type) C57BL/6 mice (age, 4-6 weeks; weight, 18-20 g)
|
|
Dosage:
|
10 mg/kg
|
|
Administration:
|
i.p.; 14 days
|
|
Result:
|
Reduced TNF-α, MMP-9 and IL-1β expression levels.
|
AUDA
上下游產(chǎn)品信息
上游原料
下游產(chǎn)品
| 更新日期 | 產(chǎn)品編號(hào) | 產(chǎn)品名稱(chēng) | CAS編號(hào) | 包裝 | 價(jià)格 |
|---|
| 2026/07/06 | S0752 | AUDA
AUDA | 479413-70-2 | 5mg | 970.12元 |
| 2026/07/06 | S0752 | AUDA | 479413-70-2 | 10mM (1mL in DMSO) | 1270元 |
479413-70-2, AUDA 相關(guān)搜索:
- 化學(xué)試劑
- 抑制劑
- 藥靶配體
- 抗體-二抗
- C23H40N2O3
- 12-(3-adamantan-1-YL-Ureido)十二烷酸
- 化合物AUDA,10 MM DMSO 溶液
- 化合物AUDA
- 12-(3-(金剛烷-1-基)脲基)十二酸
- 479413-70-2
- 12-(3-adamantan-1-Y-L-Ureido)dodecaneacid
- AUDA,≥98%
- AUDA, 10 mM in DMSO
- Inhibitor,anti-inflammatory,epoxide,inhibit,hydrolase,sEH,activity,AUDA,soluble,Epoxide Hydrolase,VSMC
- Dodecanoic acid, 12-[[(tricyclo[3.3.1.13,7]dec-1-ylamino)carbonyl]amino]-
- 12-(3-adamantan-1-yl-ureido)dodecanoic acid
- 12-[[(tricyclo[3.3.1.13,7]dec-1-ylamino)carbonyl]amino]-dodecanoic acid
- AUDA